Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy

Cancer Gene Therapy

Volumn 8, Issue 7, 2001, Pages 491-496

  Rodolfo, Monica ^a   Catò, Enrica Mira ^b   Soldati, Sabina ^b,c   Ceruti, Roberta ^b,c   Asioli, Marco ^a   Scanziani, Eugenio ^c   Vezzoni, Paolo ^b   Parmiani, Giorgio ^a   Sacco, Maria Grazia ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Angiostatin; Gene therapy; Liposomes; Melanoma

Indexed keywords

ANGIOSTATIN; COMPLEMENTARY DNA; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL DENSITY; CONTROLLED STUDY; DNA DRUG COMPLEX; GENE THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; MELANOMA; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANGIOSTATINS; ANIMALS; CELL DIVISION; DNA; DNA, COMPLEMENTARY; GENE THERAPY; HUMANS; LAC OPERON; LIPOSOMES; MELANOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PLASMINOGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0034910635     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700331     Document Type: Article

References (34)

1. Biology of tumour progression in human melanocytes
2. The prognostic significance of tumour vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study
3. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis
4. Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase
5. Angiogenesis is prognostically important in vertical growth phase melanomas
6. The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects
7. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas
8. Angiogenesis correlates with metastases in melanoma
9. Cancer: Looking outside the genome
10. Angiostatin induces and sustains dormancy of human primary tumors in mice
11. Angiostatin gene transfer: Inhibition of tumour growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest
12. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA
13. Liposomes complexed to plasmid encoding angiostatin and endostatin inhibit breast cancer in nude mice
14. Liposome-delivered angiostatin strongly inhibits tumour growth and metastatization in a transgenic model of spontaneous breast cancer
15. Systemic gene delivery expands the repertoire of effective antiangiogenic agents
16. Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumour growth and metastatization in MMTV neu transgenic mice
17. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium
18. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
19. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
20. Angiogenesis in breast cancer: A comparative study of the observer variability of methods for determining microvessel density
21. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
22. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
23. Basic fibroblast growth factor in human melanoma
24. Vascular permeability factor expression influences turnout angiogenesis in human melanoma lines xenografted to nude mice
25. Role of Interleukin-8 in tumour growth and metastasis of human melanoma
26. Hypoxia-induced upregulation of angiogenin in human malignant melanoma
27. Vascular endothelial growth factor, interleukin 8, plateled-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts
28. Angiogenic balance in human melanoma: Expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo
29. Advances in melanoma therapy
30. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy
31. Novel applications of liposomes
32. Inhibition of tumour growth correlates with the expression level of a human angiostatin transgene in transfected B16F10 melanoma cells
33. Angiostatin inhibits endothelial an melanoma cellular invasion by blocking matrix-enhanced plasminogen activation
34. Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential